- Zacks•3 days ago
Keryx Biopharmaceuticals, Inc. (KERX) is expected to report fourth-quarter 2016 results on Mar 1.
- GlobeNewswire•5 days ago
BOSTON, Feb. 23, 2017-- Keryx Biopharmaceuticals, Inc.,, a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced it will webcast its corporate ...
- GlobeNewswire•12 days agoKeryx Biopharmaceuticals to Host Conference Call of Fourth Quarter and Full Year 2016 Financial Results on Wednesday, March 1, 2017
BOSTON, Feb. 16, 2017-- Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on bringing innovative medicines to market for people with renal disease, today announced that it will host a ...
KERX : Summary for Keryx Biopharmaceuticals, Inc. - Yahoo Finance
Keryx Biopharmaceuticals, Inc. (KERX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.35 x 2500|
|Ask||5.50 x 5000|
|Day's Range||4.95 - 5.26|
|52 Week Range||3.99 - 7.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-3.36|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|